{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:54:36Z","timestamp":1791014076959,"version":"4.1.0"},"reference-count":47,"publisher":"Japanese Pharmacological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1254\/jphs.cpj06015x","type":"journal-article","created":{"date-parts":[[2006,10,19]],"date-time":"2006-10-19T01:46:44Z","timestamp":1161222404000},"page":"147-154","source":"Crossref","is-referenced-by-count":76,"title":["Development of Genetically Engineered Mice Lacking All Three Nitric Oxide Synthases"],"prefix":"10.1254","volume":"102","author":[{"given":"Masato","family":"Tsutsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.63.1.175"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.24.1.175"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.30.1.535"},{"key":"4","unstructured":"4 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–142."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Murad F. What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle? Circulation. 1997;95:1101–1103.","DOI":"10.1161\/01.CIR.95.5.1101"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1998.0841"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Godecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Godecke S, et al. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res. 1998;82:186–194.","DOI":"10.1161\/01.RES.82.2.186"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Gyurko R, Leupen S, Huang PL. Deletion of exon 6 of the neuronal nitric oxide synthase gene in mice results in hypogonadism and infertility. Endocrinology. 2002;143:2767–2774.","DOI":"10.1210\/endo.143.7.8921"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90615-W"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239–242.","DOI":"10.1038\/377239a0"},{"issue":"23","key":"11","doi-asserted-by":"crossref","first-page":"10688","DOI":"10.1073\/pnas.92.23.10688","volume":"92","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90085-3"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1038\/378383a0"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.23.13176"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81796-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Tranguch S, Huet-Hudson Y. Decreased viability of nitric oxide synthase double knockout mice. Mol Reprod Dev. 2003;65:175–179.","DOI":"10.1002\/mrd.10274"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1038\/375408a0"},{"issue":"5180","key":"18","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1126\/science.7522345","volume":"265","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199609000-00023"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Yogo K, Shimokawa H, Funakoshi H, Kandabashi T, Miyata K, Okamoto S, et al. Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol. 2000;20:E96–E100.","DOI":"10.1161\/01.ATV.20.11.e96"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502236102"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Shimokawa H, Flavahan NA, Vanhoutte PM. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res. 1989;65:740–753.","DOI":"10.1161\/01.RES.65.3.740"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation. 1991;83:652–660.","DOI":"10.1161\/01.CIR.83.2.652"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199602000-00018"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Tsutsui M, Shimokawa H, Tanaka S, Kuwaoka I, Hase K, Nogami N, et al. Endothelial Gi protein in human coronary arteries. Eur Heart J. 1994;15:1261–1266.","DOI":"10.1093\/oxfordjournals.eurheartj.a060662"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Huraux C, Makita T, Kurz S, Yamaguchi K, Szlam F, Tarpey MM, et al. Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. Circulation. 1999;99:53–59.","DOI":"10.1161\/01.CIR.99.1.53"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Kinoshita H, Tsutsui M, Milstien S, Katusic ZS. Tetrahydrobiopterin, nitric oxide and regulation of cerebral arterial tone. Prog Neurobiol. 1997;52:295–302.","DOI":"10.1016\/S0301-0082(97)00017-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Tsutsui M, Milstien S, Katusic ZS. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res. 1996;79:336–342.","DOI":"10.1161\/01.RES.79.2.336"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Tsutsui M, Chen AF, O’Brien T, Crotty TB, Katusic ZS. Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium. Arterioscler Thromb Vasc Biol. 1998;18:1231–1241.","DOI":"10.1161\/01.ATV.18.8.1231"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Tsutsui M, Onoue H, Iida Y, Smith L, O’Brien T, Katusic ZS. Adventitia-dependent relaxations of canine basilar arteries transduced with recombinant eNOS gene. Am J Physiol. 1999;276:H1846–H1852.","DOI":"10.1152\/ajpheart.1999.276.6.H1846"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Tsutsui M, Onoue H, Iida Y, Smith L, O’Brien T, Katusic ZS. Effects of recombinant eNOS gene expression on reactivity of small cerebral arteries. Am J Physiol. 2000;278:H420–H427.","DOI":"10.1152\/ajpheart.2000.278.2.H420"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Tsutsui M, Onoue H, Iida Y, Smith L, O’Brien T, Katusic ZS. B1 and B2 bradykinin receptors on adventitial fibroblasts of cerebral arteries are coupled to recombinant eNOS. Am J Physiol. 2000;278:H367–H372.","DOI":"10.1152\/ajpheart.2000.278.2.H367"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Suda O, Tsutsui M, Morishita T, Tanimoto A, Horiuchi M, Tasaki H, et al. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice. Circulation. 2002;106:1729–1735.","DOI":"10.1161\/01.CIR.0000029749.16101.44"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, Nakata S, et al. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice. Arterioscler Thromb Vasc Biol. 2004;24:1682–1688.","DOI":"10.1161\/01.ATV.0000136656.26019.6e"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Morishita T, Tsutsui M, Shimokawa H, Horiuchi M, Tanimoto A, Suda O, et al. Vasculoprotective roles of neuronal nitric oxide synthase. FASEB J. 2002;16:1994–1996.","DOI":"10.1096\/fj.02-0155fje"},{"issue":"2","key":"36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5551\/jat.11.41","volume":"11","author":"TSUTSUI M","year":"2004","ISSN":"https:\/\/id.crossref.org\/issn\/1340-3478","issn-type":"print"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Kuhlencordt PJ, Hotten S, Schodel J, Rutzel S, Hu K, Widder J, et al. Atheroprotective effects of neuronal nitric oxide synthase in apolipoprotein e knockout mice. Arterioscler Thromb Vasc Biol. 2006;26:1539–1544.","DOI":"10.1161\/01.ATV.0000223143.88128.19"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Nakata S, Tsutsui M, Shimokawa H, Tamura M, Tasaki H, Morishita T, et al. Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor: involvement of the MEK\/ERK pathway. Arterioscler Thromb Vasc Biol. 2005;25:2502–2508.","DOI":"10.1161\/01.ATV.0000190663.88143.97"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005940202801"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Lundberg JO, Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol. 2005;25:915–922.","DOI":"10.1161\/01.ATV.0000161048.72004.c2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Koizumi C, Brown WD. Formation of nitric oxide myoglobin by nicotinamide adenine dinucleotides and flavins. J Food Sci. 1971;36:1105–1109.","DOI":"10.1111\/j.1365-2621.1971.tb03357.x"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.54.1.729"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res. 2002;90:270–276.","DOI":"10.1161\/hh0302.104462"},{"issue":"2\/3","key":"44","first-page":"161","volume":"220","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(98)00009-4"},{"key":"46","unstructured":"46 Nagasaki M, Tsutsui M, Shimokawa H, Morishita T, Nakata S, Sabanai K, et al. Spontaneous development of systemic arteriosclerosis in mice lacking all nitric oxide synthase isoforms. Circulation. 2005;112:II-166."},{"key":"47","unstructured":"47 Nakata S, Tsutsui M, Sabanai K, Morishita T, Nagasaki M, Yanagihara N. A new animal model of multiple risk factor syndrome: mice lacking all nitric oxide synthase isoforms. Circulation. 2005;112:II-56."}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T11:13:37Z","timestamp":1621422817000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/102\/2\/102_2_147\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.cpj06015x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1059713.511625","asserted-by":"object"}]},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}